NCT03927521View on ClinicalTrials.gov

Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

March 11, 2024

Study Completion Date

March 11, 2024

Conditions
Prostate Cancer
Interventions
PROCEDURE

Focal HIFU using PET-MRI/68Ga-PSMA imaging guidance

Focal HIFU treatment will be conducted with the Focal One® device using the PET-MRI/68Ga-PSMA imaging. The treatment area will be defined using PET-MRI/68Ga-PSMA imaging data and 3D biopsies.

Trial Locations (1)

69437

Service d'Urologie et Chirurgie de la Transplantation - Hôpital Edouard Herriot - Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03927521 - Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study | Biotech Hunter | Biotech Hunter